[Focused Ultrasound Neuromodulation](/therapeutics/focused-ultrasound-neuromodulation) (FUS) is a non-invasive technique that uses focused acoustic energy to modulate neural activity in specific [brain regions](/brain-regions/). Unlike surgical interventions, FUS achieves targeted neuromodulation without craniotomy or implanted devices, making it particularly attractive for treating [neurodegenerative diseases](/diseases/neurodegenerative-disease) where patient safety and minimally invasive approaches are paramount.[@tyler2018]
The technology works by delivering precisely focused ultrasound waves to a specific brain target, where mechanical pressure waves interact with neuronal membranes and can either excite or inhibit neural firing depending on the ultrasound parameters (frequency, intensity, duration).[@maher2019]
Mechanism of Action
Biophysical Mechanisms
FUS modulates neural activity through several biophysical mechanisms:
Mechanical Effects: Ultrasound pressure waves create mechanical deformation of neuronal membranes, affecting [ion channel](/proteins/ion-channels) function and neuronal excitability.
Cavitation: Inertial cavitation (microbubble formation and collapse) can enhance neuromodulation effects by creating localized mechanical stress.
Thermal Effects: At higher intensities, focused ultrasound can produce localized heating, though low-intensity FUS (LIFU) avoids significant thermal effects.
Blood-Brain Barrier Modulation: FUS can temporarily open the [blood-brain barrier](/mechanisms/blood-brain-barrier-dysfunction), potentially enhancing drug delivery for neurodegenerative disease treatment.[@burgess2021]
Neural Pathway Effects
Excitatory Effects: Low-intensity FUS at certain frequencies can increase neuronal firing rates, useful for activating underactive circuits in [Parkinson's disease](/diseases/parkinsons-disease).
Inhibitory Effects: Higher intensity or specific parameter combinations can suppress neural activity, potentially for targeting hyperactive circuits in conditions like [essential tremor](/diseases/essential-tremor).
Network Modulation: FUS affects entire neural networks, not just single neurons, making it suitable for addressing circuit-level dysfunction in [neurodegenerative diseases](/diseases/neurodegenerative-disease).[@pouget2020]
Clinical Applications in Neurodegeneration
Parkinson's Disease
FUS shows particular promise for PD treatment:
Tremor Suppression: [Focused ultrasound thalamotomy](/therapeutics/focused-ultrasound-thalamotomy) (Exablate Neuro, Insightec) is FDA-approved for treating [essential tremor](/diseases/essential-tremor) and has shown efficacy for PD tremor.[@food2022]
Motor Function Improvement: Targets include the [thalamus](/brain-regions/thalamus), [subthalamic nucleus](/cell-types/subthalamic-nucleus), and [globus pallidus internus](/brain-regions/globus-pallidus).
Non-Motor Symptoms: Research explores FUS for PD-associated dysautonomia and cognitive symptoms.
Alzheimer's Disease
FUS applications in AD include:
Amyloid Clearance: Animal studies show FUS can enhance clearance of [amyloid-beta plaques](/mechanisms/amyloid-beta-aggregation) by temporarily opening the [blood-brain barrier](/mechanisms/blood-brain-barrier-dysfunction).[@leinenga2015]
Memory Enhancement: [Hippocampal](/brain-regions/hippocampus) FUS targeting may enhance memory consolidation and retrieval.
Neuroprotection: FUS may promote [neurotrophic factor](/proteins/bdnf-protein) release and reduce [neuroinflammation](/mechanisms/neuroinflammation).
Amyotrophic Lateral Sclerosis (ALS)
Emerging applications include:
Motor cortex targeting to preserve [motor neuron](/cell-types/motor-neurons) function
Bulbar function preservation for speech and swallowing
[Autonomic nervous system](/mechanisms/autonomic-nervous-system) modulation for respiratory support
Multiple System Atrophy (MSA)
Targeting of specific [brainstem nuclei](/brain-regions/brainstem) affected in [MSA](/diseases/multiple-system-atrophy)
[Autonomic function modulation](/therapeutics/autonomic-dysfunction-therapy)
Technology Platforms
Current FDA-Approved Systems
| Company | Device | Approval | Target | |---------|--------|----------|--------| | Insightec | Exablate Neuro | FDA (2020) | Thalamus for essential tremor | | Insightec | Exablate Neuro | FDA (2022) | PD tremor | | Theraclion | EchoMagic | CE Mark | Various neurological targets |
Research Systems
Harvard/Boston University LIFU System: Low-intensity focused ultrasound for neuromodulation research
Insurance Coverage: Limited coverage for some indications
Access: Available only at specialized centers with MRI-FUS equipment
Research Frontiers
Emerging Applications
Blood-Brain Barrier Opening: Enhancing [drug delivery](/therapeutics/drug-delivery-neurodegeneration) for neurological diseases
Blood-Brain Barrier Opening for Immunotherapy: Enabling antibody-based treatments for [AD](/diseases/alzheimers-disease) and [PD](/diseases/parkinsons-disease)
Opening BBB for [Gene Therapy](/therapeutics/gene-therapy-neurodegeneration): Combining FUS with viral vector delivery
Closed-Loop Systems: Real-time neural monitoring with FUS feedback
Sonogenetics: Using ultrasound to activate genetically modified [neurons](/cell-types/neurons)
Network Mapping: Using FUS to map functional brain connectivity
Ongoing Clinical Trials
NCT05019087: FUS for [Parkinson's disease](/diseases/parkinsons-disease) motor symptoms
NCT05223960: FUS for [Alzheimer's disease](/diseases/alzheimers-disease) cognitive enhancement
NCT05324068: FUS combined with [anti-amyloid immunotherapy](/therapeutics/immunotherapy-alzheimers)
Cross-References
[Deep Brain Stimulation](/treatments/deep-brain-stimulation) — Surgical alternative
[Tyler et al., (2018). Focused ultrasound: A novel tool for neuromodulation. Nature Reviews Neurology (2018)](https://doi.org/10.1038/s41582-018-0028-5)
[Maher et al., (2019). Ultrasound neuromodulation: A review of current status and future directions. Brain Stimulation (2019)](https://doi.org/10.1016/j.brs.2019.04.012)
[Burgess et al., (2021). Blood-brain barrier opening with focused ultrasound for drug delivery. Nature Reviews Drug Discovery (2021)](https://doi.org/10.1038/s41573-021-00256-8)
[Pouget et al., (2020). Emerging opportunities and challenges for focused ultrasound in neurology. Brain (2020)](https://doi.org/10.1093/brain/awaa144)
Unknown, Food and Drug Administration (2022). Exablate Neuro: FDA Approval Summary (2022)
[Leinenga et al., (2015). Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model. Science Translational Medicine (2015)](https://doi.org/10.1126/scitranslmed.aab1560)
[Elias et al., (2016). A randomized trial of focused ultrasound thalamotomy for essential tremor. New England Journal of Medicine (2016)](https://doi.org/10.1056/NEJMoa1600159)
[Jordão et al., (2019). Antibody delivery and immune cell activation by focused ultrasound enhances amyloid clearance in Alzheimer's disease models. Nature Communications (2019)](https://doi.org/10.1038/s41467-019-09518-9)
Pathway Diagram
The following diagram shows the key molecular relationships involving Focused Ultrasound Neuromodulation discovered through SciDEX knowledge graph analysis: